The median list price for newly approved U.S. prescription drugs, adjusted for inflation, rose 24% from 2022 to $293,000 in 2025.

From the articleNew ICER report suggests drug launch prices are outpacing their worthAlso in Launch prices for new medicines dipped slightly last year but remain high, analysis finds